智慧药丸技术市场规模、份额和成长分析（按目标领域、适用疾病、应用、最终用户和地区）：产业预测（2025-2032）

2023年全球智慧药丸技术市场规模为39亿美元，从2024年的42.3亿美元成长到2032年的81.3亿美元，预测期（2025-2032）预计复合年增长率将达到8.5%。

智慧药丸是数位健康领域的重要进步，具有胶囊式设计和检测、成像和标靶药物传输等先进功能。这些创新设备可透过胃肠道取得先前难以取得的诊断影像，有效地作为内视镜检查等传统方法的非侵入性替代方法。智慧药丸通常与穿戴式感测器贴片集成，通讯，使医疗保健专业人员能够密切监控患者资料。它有助于诊断胃轻瘫和便秘等胃肠道疾病，并提高用药依从性。此系统可捕捉脉搏、体温、胃酸碱度等重要指标，全面了解患者的健康状况，彻底改变胃肠疾病的诊断和治疗方法。

目录

介绍

• 分析目的
• 市场范围
• 定义

分析方法

• 资讯采购
• 次要/主要资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特分析

主要市场考虑因素

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场魅力指数（2024）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术分析
• 监管分析
• 专利分析
• 案例研究

全球智慧药丸技术市场规模与复合年增长率：依目标领域（2025-2032）

• 市场概况
• 食道
• 胃
• 小肠
• 冒号

全球智慧药丸技术市场规模及复合年增长率：依适用疾病分类（2025-2032）

• 市场概况
• 巴瑞特氏食道症
• 小肠疾病
• 大肠直肠癌
• 其他的

全球智慧药丸技术市场规模与复合年增长率：按应用分类（2025-2032）

• 市场概况
• 胶囊内视镜
• 药物输送
• 病患监测
• 其他的

全球智慧药丸技术市场规模与复合年增长率：按最终用户划分（2025-2032）

• 市场概况
• 医院/诊所
• 诊断中心
• 研究中心

全球智慧药丸技术市场规模/复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市场占有率（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• IntroMedic 有限公司（韩国）
• CapsoVision, Inc.（美国）
• Koninklijke Philips NV（荷兰）
• 奥林巴斯公司（日本）
• RF株式会社（日本）
• 总部有限公司（美国）
• Proteus 数位健康（美国）
• 美敦力公司（爱尔兰）
• 重庆金山科技(集团)有限公司 (中国)
• 检查-Cap 有限公司（以色列）
• AnX Robotica Corp.（美国）
• 深圳市吉復医疗科技有限公司 (中国)
• etecRx（美国）
• BodyCap (France)
• 大冢美国製药公司（美国）
• GE医疗集团（美国）
• 波士顿科学公司（美国）
• Give Imaging Ltd.（现为美敦力公司的一部分）（以色列）
• Bio-Images Research Limited（英国）
• Lucid 诊断（美国）

结论和建议

Global Smart Pills Technology Market size was valued at USD 3.9 billion in 2023 and is poised to grow from USD 4.23 billion in 2024 to USD 8.13 billion by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).

Smart pills represent a significant advancement in digital health, characterized by their capsule-like design and advanced capabilities such as sensing, imaging, and targeted medication delivery. These innovative devices navigate the gastrointestinal tract to capture diagnostic images that were previously challenging to obtain, effectively serving as non-invasive alternatives to traditional methods like endoscopy. Smart pills often integrate with a wearable sensor patch that communicates with a provider portal and a mobile app, allowing healthcare professionals to closely monitor patient data. They facilitate diagnosis of gastrointestinal conditions, including gastroparesis and constipation, and enhance medication adherence. This system captures vital metrics like pulse rate, body temperature, and gastric pH, offering a comprehensive view of patient health and revolutionizing the approach to diagnosing and managing gastrointestinal disorders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Pills Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Pills Technology Market Segmental Analysis

Global Smart Pills Technology Market is segmented by Target Area, Disease Indication, Application, End User and region. Based on Target Area, the market is segmented into Esophagus, Stomach, Small Intestine and Large Intestine. Based on Disease Indication, the market is segmented into Barrett's Esophagus, Small Bowel Diseases, Colon Cancer and Others. Based on Application, the market is segmented into Capsule Endoscopy,Drug Delivery,Patient Monitoring and Others. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Pills Technology Market

The global smart pills technology market is poised for substantial growth in the foreseeable future, primarily fueled by the increasing incidence of gastrointestinal disorders, including motility issues, colon cancer, obscure gastrointestinal bleeding, and Crohn's disease. Lifestyle factors such as sedentary habits are also contributing to this rising demand, alongside enhanced patient compliance thanks to minimally invasive techniques associated with smart pills. Furthermore, the market is expected to benefit from the evolving health challenges linked to modern lifestyles. As disposable incomes rise in both developed and emerging markets, more individuals will have the financial means to invest in these innovative technologies. The aging population, particularly those susceptible to inflammatory bowel diseases like ulcerative colitis and Crohn's disease, will also serve as a significant driver for market expansion.

Restraints in the Global Smart Pills Technology Market

The Global Smart Pills Technology market faces several constraints that hinder its growth despite the numerous benefits offered by this innovative technology. Key challenges include the limited technological advancement of capsule endoscopes and patients' concerns regarding the ingestion of microchips. Moreover, the high prices associated with ingestible sensors, combined with stringent government regulations governing their usage, further restrict market expansion. In developing countries, inadequate reimbursement policies often result in insufficient patient coverage, exacerbating the issue. Additionally, the technological shortcomings of various smart pill applications impede their widespread adoption throughout the forecast period, posing significant barriers to market progress.

Market Trends of the Global Smart Pills Technology Market

The Global Smart Pills Technology market is experiencing significant growth, driven by the increasing demand for innovative, AI-IoT solutions like the Smart Pill Expert System (SPES). As healthcare systems face challenges such as Medical Non-Adherence (MNA), SPES provides a reliable platform for automating medication administration and enhancing patient monitoring in nursing homes, hospices, and home healthcare facilities. Its ability to serve multiple users simultaneously while maintaining a low failure rate underscores its potential to improve medication adherence and patient outcomes. Additionally, the integration of advanced chatbots for real-time health assessments further distinguishes SPES, positioning it as a frontrunner in the evolving healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Smart Pills Technology Market Size by Target Area & CAGR (2025-2032)

• Market Overview
• Esophagus
• Stomach
• Small Intestine
• Large Intestine

Global Smart Pills Technology Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Barrett'S Esophagus
• Small Bowel Diseases
• Colon Cancer
• Others

Global Smart Pills Technology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Capsule Endoscopy
• Drug Delivery
• Patient Monitoring
• Others

Global Smart Pills Technology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Diagnostic Centres
• Research Centres

Global Smart Pills Technology Market Size & CAGR (2025-2032)

• North America (Target Area, Disease Indication, Application, End User)
  • US
  • Canada
• Europe (Target Area, Disease Indication, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Target Area, Disease Indication, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Target Area, Disease Indication, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Target Area, Disease Indication, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IntroMedic Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CapsoVision, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RF Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HQ, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteus Digital Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc. (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chongqing Jinshan Science & Technology (Group) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Check-Cap Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AnX Robotica Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Jifu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• etecRx (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BodyCap (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka America Pharmaceutical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Given Imaging Ltd. (Now part of Medtronic) (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Images Research Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lucid Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations